Papanikolaou, E., Georgomanoli, M., Stamateris, E., Panetsos, F., Karagiorga, M., Tsaftaridis, P., . . . Anagnou, N. P. (2012). The New Self-Inactivating Lentiviral Vector for Thalassemia Gene Therapy Combining Two HPFH Activating Elements Corrects Human Thalassemic Hematopoietic Stem Cells. Mary Ann Liebert, Inc.
Dyfyniad Arddull ChicagoPapanikolaou, Eleni, Maria Georgomanoli, Evangelos Stamateris, Fottes Panetsos, Markisia Karagiorga, Panagiotis Tsaftaridis, Stelios Graphakos, and Nicholas P. Anagnou. The New Self-Inactivating Lentiviral Vector for Thalassemia Gene Therapy Combining Two HPFH Activating Elements Corrects Human Thalassemic Hematopoietic Stem Cells. Mary Ann Liebert, Inc, 2012.
Dyfyniad MLAPapanikolaou, Eleni, et al. The New Self-Inactivating Lentiviral Vector for Thalassemia Gene Therapy Combining Two HPFH Activating Elements Corrects Human Thalassemic Hematopoietic Stem Cells. Mary Ann Liebert, Inc, 2012.